Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Amortizatization of Intangibles: 2017-2025

Historic Amortizatization of Intangibles for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to $3.0 million.

  • Arcus Biosciences' Amortizatization of Intangibles fell 50.00% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year decrease of 36.00%. This contributed to the annual value of $25.0 million for FY2024, which is 31.58% up from last year.
  • Arcus Biosciences' Amortizatization of Intangibles amounted to $3.0 million in Q3 2025, which was down 0.00% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' Amortizatization of Intangibles registered a high of $7.0 million during Q2 2024, and its lowest value of -$2.2 million during Q4 2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $5.0 million (2023), whereas its average is $4.9 million.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first plummeted by 2,700.00% in 2021, then surged by 407.69% in 2022.
  • Arcus Biosciences' Amortizatization of Intangibles (Quarterly) stood at -$2.2 million in 2021, then surged by 191.07% to $2.0 million in 2022, then spiked by 200.00% to $6.0 million in 2023, then remained steady at $6.0 million in 2024, then crashed by 50.00% to $3.0 million in 2025.
  • Its Amortizatization of Intangibles was $3.0 million in Q3 2025, compared to $3.0 million in Q2 2025 and $4.0 million in Q1 2025.